We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
- Authors
Sarkisian, Christopher J; Keister, Blaine A; Stairs, Douglas B; Boxer, Robert B; Moody, Susan E; Chodosh, Lewis A
- Abstract
Activating Ras mutations can induce either proliferation or senescence depending on the cellular context. To determine whether Ras activation has context-dependent effects in the mammary gland, we generated doxycycline-inducible transgenic mice that permit Ras activation to be titrated. Low levels of Ras activation - similar to those found in non-transformed mouse tissues expressing endogenous oncogenic Kras2 - stimulate cellular proliferation and mammary epithelial hyperplasias. In contrast, high levels of Ras activation - similar to those found in tumours bearing endogenous Kras2 mutations - induce cellular senescence that is Ink4a-Arf- dependent and irreversible following Ras downregulation. Chronic low-level Ras induction results in tumour formation, but only after the spontaneous upregulation of activated Ras and evasion of senescence checkpoints. Thus, high-level, but not low-level, Ras activation activates tumour suppressor pathways and triggers an irreversible senescent growth arrest in vivo. We suggest a three-stage model for Ras-induced tumorigenesis consisting of an initial activating Ras mutation, overexpression of the activated Ras allele and, finally, evasion of p53-Ink4a-Arf-dependent senescence checkpoints.
- Publication
Nature cell biology, 2007, Vol 9, Issue 5, p493
- ISSN
1465-7392
- Publication type
Journal Article
- DOI
10.1038/ncb1567